← back to search

S. Picaud

University of Oxford · GB
Area of research
Molecular Biology · Hematology
Research interest
Research interests include Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments, Advanced biosensing and bioanalysis techniques, and Ubiquitin and proteasome pathways.
h-index
42
citations
11,906
works
185
NIH funding
primary concept
email

Recent publications

Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains
Molecular Cell 2018cited by 187position: middledoi
Nut Directs p300-Dependent, Genome-Wide H4 Hyperacetylation in Male Germ Cells
Cell Reports 2018cited by 95position: middledoi
Promiscuous targeting of bromodomains by bromosporine identifies BET proteins as master regulators of primary transcription response in leukemia
Science Advances 2016cited by 110position: firstdoi
Identification of a Chemical Probe for Family VIII Bromodomains through Optimization of a Fragment Hit
Journal of Medicinal Chemistry 2016cited by 109position: middledoi
Selective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenance
Science Advances 2015cited by 143position: middledoi
Dual kinase-bromodomain inhibitors for rationally designed polypharmacology
Nature Chemical Biology 2014cited by 349position: middledoi
PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains
Cancer Research 2013cited by 247position: firstdoi
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
Cell 2012cited by 1,735position: middledoi
Small-Molecule Inhibition of BRDT for Male Contraception
Cell 2012cited by 418position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

P. Filippakopoulos · University of Oxford8 papers (2012–2018)Stefan Knapp · Goethe University Frankfurt5 papers (2012–2016)Susanne Müller · University of Stuttgart5 papers (2012–2016)Anne‐Claude Gingras · University of Toronto3 papers (2012–2018)Christopher Wells · Indiana University School of Medicine3 papers (2014–2016)Jean‐Philippe Lambert · Université Laval3 papers (2012–2018)Paul E. Brennan · University of Birmingham3 papers (2013–2016) · 2 papers (2015–2016)James E. Bradner · Novartis (China)2 papers (2012–2013) · 2 papers (2016–2018)Juerg Schwaller · University of Birmingham2 papers (2013–2016)Dafydd R. Owen · Pfizer (United States)2 papers (2013–2015)Mark E. Bunnage · University of Birmingham2 papers (2013–2015)Octovia Monteiro · PharmatrophiX (United States)2 papers (2015–2016)Martin Philpott · University of Birmingham2 papers (2013–2015)Sarah Martin · Australian National University2 papers (2014–2015) · 2 papers (2015–2016)O. Fedorov · University of Birmingham2 papers (2013–2014) · 1 papers (2016–2016) · 1 papers (2018–2018)